MedTrace Logo

The TELEAP1 CPAP-telemonitoring Study

NCT04897646 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-05-21

No results posted yet for this study

Summary

TELEAP1 is a multicenter cohort pilot-study designed to evaluate the impact of a published SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm on the CPAP-compliance of newly treated patients with obstructive sleep apnea..

Conditions

Interventions

OTHER

SFRMS/SPLF CPAP-telemonitoring diagnosis/therapeutic algorithm.

In 2020, a working group from the Société Française de Recherche et de Médecine du Sommeil (SFRMS) and the Société de Pneumologie de Langue Française (SPLF) have proposed a CPAP-telemonitoring diagnosis/therapeutic algorithm for newly treated patients with obstructive sleep apnea. The algorithm is exhasutively described in the following published article: Prigent, A., Gentina, T., Launois, S., et al. \[Telemonitoring in continuous positive airway pressure-treated patients with obstructive sleep apnoea syndrome: An algorithm proposal\]. Rev. Mal. Respir., 2020, 37: 550-560.

Sponsors & Collaborators

  • ADENE, Montpellier

    collaborator UNKNOWN

  • AGIR à dom, Meylan

    collaborator UNKNOWN

  • ASTEN sante, Pays de la Loire

    collaborator UNKNOWN

  • ELIA medical, Cesson-Sévigné

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Dany Jaffuel, MD,PhD · Montpellier University Hospitals

  • Fréderic Gagnadoux · University Hospital, Angers

  • Arnaud Prigent · Polyclinique Saint Laurent - Rennes

  • Renaud Tamisier, MD, PhD · University Hospital, Grenoble

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-12-15
Completion
2023-12-15

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04897646 on ClinicalTrials.gov